TRAMETINIB DIMETHYL SULFOXIDE Drug Patent Profile
✉ Email this page to a colleague
When do Trametinib Dimethyl Sulfoxide patents expire, and what generic alternatives are available?
Trametinib Dimethyl Sulfoxide is a drug marketed by Novugen and is included in one NDA.
The generic ingredient in TRAMETINIB DIMETHYL SULFOXIDE is trametinib dimethyl sulfoxide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAMETINIB DIMETHYL SULFOXIDE?
- What are the global sales for TRAMETINIB DIMETHYL SULFOXIDE?
- What is Average Wholesale Price for TRAMETINIB DIMETHYL SULFOXIDE?
Summary for TRAMETINIB DIMETHYL SULFOXIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 15 |
| Patent Applications: | 152 |
| DailyMed Link: | TRAMETINIB DIMETHYL SULFOXIDE at DailyMed |
Recent Clinical Trials for TRAMETINIB DIMETHYL SULFOXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| ECOG-ACRIN Cancer Research Group | Phase 2 |
| Pediatric Brain Tumor Consortium | Phase 1/Phase 2 |
| National Cancer Institute (NCI) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for TRAMETINIB DIMETHYL SULFOXIDE
Paragraph IV (Patent) Challenges for TRAMETINIB DIMETHYL SULFOXIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| MEKINIST | Tablets | trametinib dimethyl sulfoxide | 0.5 mg and 2 mg | 204114 | 1 | 2023-09-28 |
US Patents and Regulatory Information for TRAMETINIB DIMETHYL SULFOXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novugen | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-001 | Aug 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novugen | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-002 | Aug 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
